IATROGENIC URETERAL INJURY TREATMENT WITH BIODEGRADABLE-ANTIREFLUX HEPARIN COATED URETERAL STENT. ANIMAL MODEL COMPARATIVE STUDY

Autor: Soria F, de la Cruz JE, Budia A, Cepeda M, Alvarez S, Serrano A, Sanchez Margallo FM

Publikováno v: JOURNAL OF ENDOUROLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

The aim is to assess the effectiveness of a biodegradable antireflux ureteral stent with heparin coating in a comparative study (BraidStent®-H) in an animal model for the treatment of iatrogenic ureteral perforation.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::222ca2736cc4dd794af03e52ae23dbe1
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13886

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning.

Autor: Kleinbongard P; Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany. petra.kleinbongard@uk-essen.de., Arriola CG; Centro Nacional de Investigaciones Cardiovasculares Carlos III, CIBER de Enfermedades Cardiovasculares (CIBERCV), Melchor Fernández Almagro 9, 28029, Madrid, Spain. carlos.galan@cnic.es., Badimon L; Research Institute Hospital de La Santa Creu I Sant Pau-IIB Sant Pau, and CIBER Enfermedades Cardiovasculares, Barcelona, Spain., Crisostomo V; Cardiovascular Area, Jesús Usón Minimally Invasive Surgery Centre (CCMIJU), Cáceres, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), RICORS-TERAV Network, ISCIII, Madrid, Spain., Giricz Z; Cardiovascular and Metabolic Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; Pharmahungary Group, Szeged, Hungary., Gyöngyösi M; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090, Vienna, Austria., Heusch G; Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany., Ibanez B; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Kiss A; Ludwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria., de Kleijn DPV; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., Podesser BK; Ludwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria., Carracedo RR; Unidad de Investigación Cardiovascular, Departamento de Cardiología, Hospital Ramón y Cajal (IRYCIS), Universidad Francisco de Vitoria, Madrid, Spain., Rodríguez-Sinovas A; Cardiovascular Diseases Research Group, Department of Cardiology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Ruiz-Meana M; Cardiovascular Diseases Research Group, Department of Cardiology, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Sanchez Margallo FM; CIBER de Enfermedades Cardiovasculares (CIBERCV), RICORS-TERAV Network, ISCIII, Madrid, Spain.; Jesús Usón Minimally Invasive Surgery Centre (CCMIJU), Cáceres, Spain., Vilahur G; Research Institute Hospital de La Santa Creu I Sant Pau-IIB Sant Pau, and CIBER Enfermedades Cardiovasculares, Barcelona, Spain., Zamorano JL; University Hospital Ramon Y Cajal, Madrid, Spain., Zaragoza C; Unidad de Investigación Cardiovascular, Departamento de Cardiología, Hospital Ramón y Cajal (IRYCIS), Universidad Francisco de Vitoria, Madrid, Spain., Ferdinandy P; Pharmahungary Group, Szeged, Hungary. peter.ferdinandy@pharmahungary.com.; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvárad Tér 4, Budapest, 1089, Hungary. peter.ferdinandy@pharmahungary.com.; Center for Pharmacology and Drug Research and Development, Semmelweis University, Budapest, Hungary. peter.ferdinandy@pharmahungary.com., Hausenloy DJ; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. derek.hausenloy@duke-nus.edu.sg.; National Heart Research Institute Singapore, National Heart Centre, Singapore, Singapore. derek.hausenloy@duke-nus.edu.sg.; Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore. derek.hausenloy@duke-nus.edu.sg.; The Hatter Cardiovascular Institute, University College London, London, UK. derek.hausenloy@duke-nus.edu.sg.

Publikováno v: Basic research in cardiology [Basic Res Cardiol] 2024 Dec; Vol. 119 (6), pp. 893-909. Date of Electronic Publication: 2024 Oct 18.

Biopolymers for Tissue Engineering: Crosslinking, Printing Techniques, and Applications.

Autor: Patrocinio D; CCMIJU, Bioengineering and Health Technologies, Jesus Usón Minimally Invasive Surgery Center, 10071 Cáceres, Spain., Galván-Chacón V; CCMIJU, Bioengineering and Health Technologies, Jesus Usón Minimally Invasive Surgery Center, 10071 Cáceres, Spain., Gómez-Blanco JC; CCMIJU, Bioengineering and Health Technologies, Jesus Usón Minimally Invasive Surgery Center, 10071 Cáceres, Spain., Miguel SP; CPIRN-IPG, Center of Potential and Innovation of Natural Resources, Polytechnic of Guarda, 6300-559 Guarda, Portugal.; CICS-UBI, Health Science Research Center, University of Beira Interior, 6201-506 Covilhã, Portugal., Loureiro J; CPIRN-IPG, Center of Potential and Innovation of Natural Resources, Polytechnic of Guarda, 6300-559 Guarda, Portugal., Ribeiro MP; CPIRN-IPG, Center of Potential and Innovation of Natural Resources, Polytechnic of Guarda, 6300-559 Guarda, Portugal.; CICS-UBI, Health Science Research Center, University of Beira Interior, 6201-506 Covilhã, Portugal., Coutinho P; CPIRN-IPG, Center of Potential and Innovation of Natural Resources, Polytechnic of Guarda, 6300-559 Guarda, Portugal.; CICS-UBI, Health Science Research Center, University of Beira Interior, 6201-506 Covilhã, Portugal., Pagador JB; CCMIJU, Bioengineering and Health Technologies, Jesus Usón Minimally Invasive Surgery Center, 10071 Cáceres, Spain.; CIBER CV, Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, 28029 Madrid, Spain., Sanchez-Margallo FM; CIBER CV, Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares, 28029 Madrid, Spain.; Scientific Direction, Jesus Usón Minimally Invasive Surgery Center, 10071 Cáceres, Spain.; TERAV/ISCIII, Red Española de Terapias Avanzadas, Instituto de Salud Carlos III (RICORS, RD21/0017/0029), 28029 Madrid, Spain.

Publikováno v: Gels (Basel, Switzerland) [Gels] 2023 Nov 10; Vol. 9 (11). Date of Electronic Publication: 2023 Nov 10.